Promoter hypermethylation may be an important mechanism of the transcriptional inactivation of ARRDC3, GATA5, and ELP3 in invasive ductal breast carcinoma

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2014-08-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11010-014-2143-yPMID 25148870
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lung cancer incidence and mortality in China, 2011

  2015cited by this paper
• Epigenetic silencing of ARRDC3 expression in basal-like breast cancer cells

  2014cited by this paper
• Identification of inherited genetic variations influencing prognosis in early-onset breast cancer.

  2013cited by this paper
• Epigenetics in breast cancer.

  2013cited by this paper
• Upstream stimulatory factor 1 activates GATA5 expression through an E-box motif.

  2012cited by this paper
• An expanded family of arrestins regulate metabolism.

  2012cited by this paper
• Cancer incidence and mortality in China, 2007

  2012cited by this paper
• Methylation analysis of tumour suppressor genes in ovarian cancer using MS-MLPA.

  2012cited by this paper
• Epigenetic Repression of RARRES1 Is Mediated by Methylation of a Proximal Promoter and a Loss of CTCF Binding

  2012cited by this paper
• Epigenetic profile in chronic lymphocytic leukemia using methylation-specific multiplex ligation-dependent probe amplification.

  2012cited by this paper
• Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer.

  2012cited by this paper
• 275 GATA5 PROMOTER METHYLATION IS ASSOCIATED WITH METASTASIS AND PROGRESSION FREE SURVIVAL IN RENAL CELL CANCER PATIENTS

  2011cited by this paper
• Identification and Validation of DNA Methylation Markers to Predict Lymph Node Metastasis of Esophageal Squamous Cell Carcinomas

  2011cited by this paper
• Regulation of Pax6 by CTCF during Induction of Mouse ES Cell Differentiation

  2011cited by this paper
• Evaluation of the methylation status of tumour suppressor genes for predicting bacillus Calmette-Guérin response in patients with T1G3 high-risk bladder tumours.

  2011cited by this paper
• Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer

  2011influential reference
• The arrestin domain-containing 3 protein regulates body mass and energy expenditure.

  2011cited by this paper
• Arrestin domain‐containing protein 3 recruits the NEDD4 E3 ligase to mediate ubiquitination of the β2‐adrenergic receptor

  2010cited by this paper
• 中国肺癌发病死亡的估计和流行趋势研究

  2010cited by this paper
• Promoter CpG island hypermethylation during breast cancer progression

  2010cited by this paper
• Identification and validation of DNA methylation markers to predict lymph node metastasis of esophageal squamous cell carcinomas

  2010cited by this paper
• The epigenetics of breast cancer

  2010cited by this paper
• Global Methylation Pattern of Genes in Androgen-Sensitive and Androgen-Independent Prostate Cancer Cells

  2010cited by this paper
• Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer

  2010cited by this paper
• A role for elongator in zygotic paternal genome demethylation

  2010cited by this paper
• ARRDC3 suppresses breast cancer progression by negatively regulating integrin β4

  2010cited by this paper
• Gata4 and Gata5 Cooperatively Regulate Cardiac Myocyte Proliferation in Mice*

  2009cited by this paper
• The Elongator Complex Interacts with PCNA and Modulates Transcriptional Silencing and Sensitivity to DNA Damage Agents

  2009cited by this paper
• DNA hypermethylation accompanied by transcriptional repression in follicular lymphoma

  2009cited by this paper
• The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

  2009cited by this paper
• GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer

  2009cited by this paper
• Methylation of the TPEF‐ and PAX6‐promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours

  2008cited by this paper
• Radiation-Induced Lung Adenocarcinoma is Associated with Increased Frequency of Genes Inactivated by Promoter Hypermethylation

  2007cited by this paper
• Biomarkers for early detection of breast cancer: what, when, and where?

  2007cited by this paper
• Elongator complex: how many roles does it play?

  2007cited by this paper
• Integrated profiling of basal and luminal breast cancers.

  2007influential reference
• GSTP1 promoter hypermethylation is an early event in breast carcinogenesis

  2007cited by this paper
• Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum

  2007cited by this paper
• Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.

  2006cited by this paper
• A PANorama of PAX genes in cancer and development

  2006cited by this paper
• Transcription impairment and cell migration defects in elongator-depleted cells: implication for familial dysautonomia.

  2006cited by this paper
• An early step in wobble uridine tRNA modification requires the Elongator complex.

  2005cited by this paper
• How to best classify breast cancer: conventional and novel classifications (review).

  2005cited by this paper
• Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual.

  2003cited by this paper
• DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma

  2003cited by this paper
• Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: A prospective study in high‐risk patients without invasive cancer.

  2002cited by this paper
• MethPrimer: designing primers for methylation PCRs

  2002cited by this paper
• Expert Commentary.

  2002cited by this paper
• DNA hypermethylation in tumorigenesis: epigenetics joins genetics.

  2000cited by this paper
• Diseases of the breast

  2000cited by this paper
• Pathological prognostic factors in breast cancer.

  1999cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• PAX genes.

  1994cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper

• PAX Family, Master Regulator in Cancer

  2025cites this paper
• Molecular mechanisms of action of curaxin CBL0137 on breast cancer cells in vitro

  2024cites this paper
• Lysine Acetyltransferases (KATS) in Disguise: Diseases Implications.

  2023cites this paper
• Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics

  2023cites this paper
• Relation between the circular and linear form of the Elongator Acetyltransferase Complex Subunit 3 in the progression of triple‐negative breast cancer

  2022influential citation
• GLAD-PCR assay of DNA methylation sites in regulatory regions of some tumor-suppressor genes in breast cancer

  2022cites this paper
• Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy

  2021cites this paper
• ARRDC3 as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer Based on Data Mining

  2021cites this paper
• Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy

  2021cites this paper
• Methylation and serum response factor mediated in the regulation of gene ARRDC3 in breast cancer.

  2020cites this paper
• Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer

  2019cites this paper
• Comprehensive analysis of the GATA transcription factor gene family in breast carcinoma using gene microarrays, online databases and integrated bioinformatics

  2019cites this paper
• Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease

  2019cites this paper
• DNA methylation patterns as molecular biomarkers: an overview in colorectal cancer

  2018cites this paper
• Elongator and codon bias regulate protein levels in mammalian peripheral neurons

  2018cites this paper
• GPCRs in Cancer: Protease-Activated Receptors, Endocytic Adaptors and Signaling

  2018cites this paper
• EBV Associated Breast Cancer Whole Methylome Analysis Reveals Viral and Developmental Enriched Pathways

  2018cites this paper
• S-Adenosylmethionine Metabolism and Aging

  2018cites this paper
• The α-arrestin ARRDC3 suppresses breast carcinoma invasion by regulating G protein–coupled receptor lysosomal sorting and signaling

  2018cites this paper
• ARRDC3 Inhibits the Progression of Human Prostate Cancer Through ARRDC3-ITGβ4 Pathway.

  2017cites this paper
• Gene expression meta-analysis in diffuse low-grade glioma and the corresponding histological subtypes

  2017cites this paper
• Epigenetic and genetic variation in GATA5 is associated with gastric disease risk

  2016cites this paper
• Aberrant methylation of tumour suppressor genes WT1, GATA5 and PAX5 in hepatocellular carcinoma

  2016cites this paper
• Promoter hypermethylation profiling of distant breast cancer metastases

  2015cites this paper
• Methylome analysis reveals dysregulated developmental and viral pathways in breast cancer

  2015cites this paper
• Pancreatic Cancer Patient Survival Correlates with DNA Methylation of Pancreas Development Genes

  2015cites this paper
• Association of GATA5 methylation with clinocopathological characteristics in non-muscle invasive bladder cancer

  2015cites this paper